Upper Urinary Tract Cancer
Phase II/III Trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Physician Fact Sheet
The EA8192 study team discusses this important phase II/III trial of durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy.